Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Oct 2003

Sethi Ajay K, Celentano David D, Gange Stephen J, Moore Richard D, Gallant Joel E

Abstract excerpt

Nonadherence to highly active antiretroviral therapy (HAART) is a major cause of human immunodeficiency virus (HIV) drug resistance; however the level of nonadherence associated with the greatest risk of resistance is unknown. Beginning in February 2000, 195 patients at the Johns Hopkins Outpatient Center (Baltimore, MD) who were receiving HAART and who had HIV loads of <500 copies/mL were recruited into a cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Guideline Adherence

Share to HIV Infections

Share to Patient Compliance

Share to Viral Load

Source

Identifiers

PMID: 14523777
DOI: 10.1086/378301

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.PMID 14523777Read ↗

Current management challenges in HIV: antiretroviral resistance.Semantic proximity Read ↗

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.Semantic proximity Read ↗

In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.Semantic proximity Read ↗

Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.Semantic proximity Read ↗

Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceSemantic proximity Read ↗

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.Semantic proximity Read ↗

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.Semantic proximity Read ↗

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.Semantic proximity Read ↗

Resistance profiles in patients with viral rebound on potent antiretroviral therapy.Semantic proximity Read ↗

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.Semantic proximity Read ↗

Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.